CXCL10/IP-10/CRG-2 Antibody (6D4) [mFluor Violet 610 SE]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-59749MFV610
Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Concentration
Product Specifications
Immunogen
Localization
Specificity
Clonality
Host
Isotype
Scientific Data Images for CXCL10/IP-10/CRG-2 Antibody (6D4) [mFluor Violet 610 SE]
CXCL10/IP-10/CRG-2 Antibody (6D4) [mFluor Violet 610 SE] [NBP2-59749MFV610] -
CXCL10/IP-10/CRG-2 Antibody (6D4) [mFluor Violet 610 SE] [NBP2-59749MFV610] - Vial of mFluor Violet 610 conjugated antibody. mFluor Violet 610 is optimally excited at 421 nm by the Violet laser (405 nm) and has an emission maximum of 613 nm.Applications for CXCL10/IP-10/CRG-2 Antibody (6D4) [mFluor Violet 610 SE]
Flow Cytometry
Immunoassay
Immunohistochemistry-Frozen
Western Blot
Formulation, Preparation, and Storage
Purification
Formulation
Preservative
Concentration
Shipping
Stability & Storage
Background: CXCL10/IP-10/CRG-2
CXCL10/IP-10 is an ELR- angiostatic chemokine that interacts with CXCR3 to attract Th1 cells, eosinophils, monocytes, and NK cells to sites of inflammation. It is upregulated by activated T lymphocytes, neutrophils, splenocytes, keratinocytes, osteoblasts, astrocytes, endothelial cells, smooth muscle cells, and pancreatic beta cells. CXCL10 contributes to disease pathology in many chronic inflammatory disorders including rheumatoid arthritis, psoriasis, cancer, multiple sclerosis, diabetes, and cardiovascular disease.
Alternate Names
Gene Symbol
Additional CXCL10/IP-10/CRG-2 Products
Product Documents for CXCL10/IP-10/CRG-2 Antibody (6D4) [mFluor Violet 610 SE]
Product Specific Notices for CXCL10/IP-10/CRG-2 Antibody (6D4) [mFluor Violet 610 SE]
mFluor(TM) is a trademark of AAT Bioquest, Inc. This conjugate is made on demand. Actual recovery may vary from the stated volume of this product. The volume will be greater than or equal to the unit size stated on the datasheet.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.